SCHEMBL1279377

SCHEMBL1279377

O=c1cc(-c2ccc(Cl)cc2)[nH]c2c(-c3cccs3)c(C(F)(F)F)nn12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARF6 P62330 8/20 0.46
PLAT P00750 1/20 0.44
MAPK14 Q16539 3/20 0.40
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1278980 0.91 ALDH1A1 (0.43) ARF6MAPK14ADORA3ALDH1A1HPGD
SCHEMBL1278976 0.87 PDE10A (0.43) MAPK14ADORA3KDM4ENPSR1LMNA
SCHEMBL19084538 0.86 ARF6 (0.58) ARF6PLATALDH1A1HPGDKDM4E
SCHEMBL1614734 0.84 MAPK14 (0.40) MAPK14ADORA3ADORA2AALDH1A1HPGD
SCHEMBL1278782 0.84 ARF6 (0.58) ARF6PLATKDM4EPOLB
SCHEMBL19084660 0.82 ARF6 (0.53) ARF6PLATMAPK14
SCHEMBL1278633 0.82 HPGD (0.38) MAPK14ADORA3ADORA2AALDH1A1HPGD
SCHEMBL1279352 0.82 ARF6 (0.59) ARF6PLATMAPK14ALDH1A1HPGD
SCHEMBL1649492 0.82 KCNQ3 (0.44) ARF6PLATMAPK14ADORA3ADORA2A
SCHEMBL1279368 0.82 SMN1; SMN2 (0.43) ALDH1A1HPGDKDM4EHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 ARF6 3851/4885PLAT 1286/4885MAPK14 2408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.